» Articles » PMID: 30845147

In Vitro Efficacy of Potentiated Egg Yolk Powder Against Campylobacter Jejuni Does Not Correlate with in Vitro Efficacy

Overview
Journal PLoS One
Date 2019 Mar 8
PMID 30845147
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Campylobacter jejuni is a zoonotic agent responsible for the foodborne gastroenteritis campylobacteriosis. Control of C. jejuni load in the poultry primary production is recognized as an avenue to reduce human exposure to the pathogen. As for now, no commercially applicable control methods exist at the farm. Several studies tested egg yolk powders, potentiated or not against C. jejuni, as feed additives for chicken and suggested that the quantity and quality of the antibodies presence in the yolk are determinant factors for the full success of this approach. Unfortunately, data from these studies inconsistently showed a reduction of cecal C. jejuni carriage. Our first goal wwas to characterize (quantification by ELISA, agglutination test, bacterial antigen recognition profiles by Western blot, bactericidal effect by serum killing assays and C. jejuni mobility by soft agar migation) the antibodies extracted from egg yolk powders originating from different egg production protocols. Secondly, these powders were microencapsulated and recharacterized. Finally the protected powders were tested as a feed additive to destabilize C. jejuni colonization in an in vivo assay. Despite the in vitro results indicating the ability of the egg yolk powders to recognize Campylobacter and potentially alter its colonization of the chicken caecum, these results were not confirmed in the in vivo trial despite that specific caecal IgY directed toward Campylobacter were detected in the groups receiving the protected powders. More research is needed on Campylobacter in order to effectively control this pathogen at the farm.

Citing Articles

Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations.

Soltani N, Rahimi S, Khaki P, Karimi Torshizi M, Eskandari B, Grimes J Poult Sci. 2025; 104(2):104718.

PMID: 39787828 PMC: 11761915. DOI: 10.1016/j.psj.2024.104718.


IgYs: on her majesty's secret service.

Grzywa R, Lupicka-Slowik A, Sienczyk M Front Immunol. 2023; 14:1199427.

PMID: 37377972 PMC: 10291628. DOI: 10.3389/fimmu.2023.1199427.


Correction: In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.

Soumaila Garba A, Thibodeau A, Perron A, Laurent-Lewandowski S, Letellier A, Fravalo P PLoS One. 2019; 14(4):e0215699.

PMID: 30990866 PMC: 6467398. DOI: 10.1371/journal.pone.0215699.

References
1.
Laisney M, Gillard M, Salvat G . Influence of bird strain on competitive exclusion of Campylobacter jejuni in young chicks. Br Poult Sci. 2004; 45(1):49-54. DOI: 10.1080/00071660410001668851. View

2.
Bolton D . Campylobacter virulence and survival factors. Food Microbiol. 2015; 48:99-108. DOI: 10.1016/j.fm.2014.11.017. View

3.
Thibodeau A, Fravalo P, Laurent-Lewandowski S, Guevremont E, Quessy S, Letellier A . Presence and characterization of Campylobacter jejuni in organically raised chickens in Quebec. Can J Vet Res. 2012; 75(4):298-307. PMC: 3187637. View

4.
Mohan V . The role of probiotics in the inhibition of Campylobacter jejuni colonization and virulence attenuation. Eur J Clin Microbiol Infect Dis. 2015; 34(8):1503-13. DOI: 10.1007/s10096-015-2392-z. View

5.
Huneau-Salaun A, Guyard-Nicodeme M, Benzoni G, Gautier X, Quesne S, Poezevara T . Randomized control trial to test the effect of a feed additive on Campylobacter contamination in commercial broiler flocks up to slaughter. Zoonoses Public Health. 2018; 65(4):404-411. DOI: 10.1111/zph.12447. View